de Boisanger, J.; Brewer, M.; Fittall, M.W.; Tran, A.; Thomas, K.; Dreibe, S.; Creak, A.; Solda, F.; Konadu, J.; Taylor, H.;
et al. Survival after Stereotactic Radiosurgery in the Era of Targeted Therapy: Number of Metastases No Longer Matters. Curr. Oncol. 2024, 31, 2994-3005.
https://doi.org/10.3390/curroncol31060228
AMA Style
de Boisanger J, Brewer M, Fittall MW, Tran A, Thomas K, Dreibe S, Creak A, Solda F, Konadu J, Taylor H,
et al. Survival after Stereotactic Radiosurgery in the Era of Targeted Therapy: Number of Metastases No Longer Matters. Current Oncology. 2024; 31(6):2994-3005.
https://doi.org/10.3390/curroncol31060228
Chicago/Turabian Style
de Boisanger, James, Martin Brewer, Matthew W. Fittall, Amina Tran, Karen Thomas, Sabine Dreibe, Antonia Creak, Francesca Solda, Jessica Konadu, Helen Taylor,
and et al. 2024. "Survival after Stereotactic Radiosurgery in the Era of Targeted Therapy: Number of Metastases No Longer Matters" Current Oncology 31, no. 6: 2994-3005.
https://doi.org/10.3390/curroncol31060228
APA Style
de Boisanger, J., Brewer, M., Fittall, M. W., Tran, A., Thomas, K., Dreibe, S., Creak, A., Solda, F., Konadu, J., Taylor, H., Saran, F., Welsh, L., & Rosenfelder, N.
(2024). Survival after Stereotactic Radiosurgery in the Era of Targeted Therapy: Number of Metastases No Longer Matters. Current Oncology, 31(6), 2994-3005.
https://doi.org/10.3390/curroncol31060228
